1-4 of 4
Authors: Andrew Mhyre
Sort by
Journal Article
EXTH-58. THERAPEUTIC HDAC INHIBITION IN HYPERMUTANT DIFFUSE INTRINSIC PONTINE GLIOMA
Alyssa Noll and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi176, https://doi.org/10.1093/neuonc/noab196.697
Published: 12 November 2021
Journal Article
MODL-28. IMMUNE PRIMING WITH INTERFERON-Γ COMBINED WITH EPIGENETIC MODULATION IN PEDIATRIC BRAIN TUMORS
Erin Crotty and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii416–iii417, https://doi.org/10.1093/neuonc/noaa222.601
Published: 04 December 2020
Journal Article
DIPG-10. OPTIMAL HDAC INHIBITION IN DIFFUSE INTRINSIC PONTINE GLIOMA
Nicholas Vitanza and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii288–iii289, https://doi.org/10.1093/neuonc/noaa222.060
Published: 04 December 2020
Journal Article
DIPG-35. A NOVEL HDAC INHIBITOR IN NEW PATIENT-DERIVED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) MODELS
Matthew Biery and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i56, https://doi.org/10.1093/neuonc/noy059.128
Published: 22 June 2018
Advertisement
Advertisement